About 1 in 7 breast cancer cases are overdiagnosed, a study published March 1 in the Annals of Internal Medicine found.
The Latest
The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28.
Vanderbilt-Ingram Cancer Center in Nashville, Tenn., has selected Ben Ho Park, MD, PhD, as its new director.
Yale Cancer Center named its annual Conclave awardees in honor of their outstanding contributions to cancer care and research.
Metformin, a drug traditionally prescribed for diabetes but recently used in clinical settings as a cancer treatment, shows "great promise" but can have negative consequences in the treatment of some cancer types, researchers at the University of Waterloo in Canada…
Researchers at the University of California San Diego Health are the first in the county to employ high-intensity, focused ultrasound as a minimally invasive prostate cancer treatment, the system said Feb. 24.
Here are four announcements from the American Cancer Society reported by Becker's since Feb. 11:
The American Cancer Society awarded over $16 million in grants to establish cancer health equity research centers at minority-serving institutions of higher learning across the country, the organization said Feb. 24.
Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian has selected Thomas Wang, MD, PhD, to serve as medical director of its melanoma/advanced skin cancer program.
Los Angeles-based City of Hope was awarded a $4.9 million grant for its department of stem cell biology and regenerative medicine, the cancer research group said Feb. 22.